This Week at FDA: Tidmarsh saga unfolds, another batch of Commissioner’s vouchers, and more

This Week at FDA

This Week at FDAFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesDigital health/SaMD/AILeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters